Weekly CFO Sells Highlights: Facebook, Tableau Software, Gilead Sciences

Recent insider sales from company CFOs

Author's Avatar
Nov 16, 2015
Article's Main Image

According to GuruFocus Insider Data, the recent CFO sales were: Facebook Inc. (FB, Financial), Tableau Software Inc. (DATA, Financial) and Gilead Sciences Inc. (GILD, Financial).

Facebook Inc.: CFO David M. Wehner sold 8,072 shares

On Aug. 20, CFO David M. Wehner sold 8,072 shares at an average price of $93.56. The price of the stock has increased by 11.11%. Facebook has a market cap of $293.97 billion and its shares were traded at around $103.95. The company has a P/E ratio of 105.20 and P/S ratio of 18.53.

Facebook announced its 2015 second-quarter results with revenues of $4.04 billion and gross profit of $3.37 billion; the net income was $715 million. The 2014 total revenue was $12.47 billion, a 58% increase from the 2013 total revenue. The 2014 gross profit was $10.31 billion, a 72% increase from the 2013 gross profit. The 2014 net income was $2.93 billion.

On Nov. 12, Director Marc L. Andreessen sold 141,522 shares at an average price of $108.72. The price of the stock has decreased by 4.39%. On Nov. 3, VP, General Counsel and Secretary Colin Stretch sold 1,000 shares at an average price of $103.35. The price of the stock has increased by 0.58%.

Tableau Software Inc.: CFO Thomas E. Walker Jr. sold 40,000 shares

On Nov. 10, CFO Thomas E. Walker Jr. sold 40,000 shares at an average price of $97.23. The price of the stock has decreased by 3.75%. Tableau Software has a market cap of $6.78 billion, and its shares were traded at around $93.58. The company has a P/S ratio of 12.00.

Tableau Software announced its 2015 third-quarter results with revenues of $170.83 million and gross profit of $150.96 million; the net income was $13.37 million. The 2014 total revenue was $412.62 million, a 78% increase from the 2013 total revenue. The 2014 gross profit was $375.63 million, a 70% increase from the 2013 gross profit. The 2014 net income was $5.87 million.

On Nov. 11, CEO, co-founder and Chairman Christian Chabot sold 150,000 shares at an average price of $95.87. The price of the stock has decreased by 2.39%. On Nov. 11, CDO and co-founder Chris Stolte sold 250,000 shares at an average price of $95.86. The price of the stock has decreased by 2.38%. On Sept. 3, Executive VP, Sales Kelly Wright sold 3,334 shares at an average price of $94.37. The price of the stock has decreased by 0.84%.

Gilead Sciences Inc.: EVP, CFO Robin L. Washington sold 6,250 shares

On Nov. 2, EVP, CFO Robin L. Washington sold 6,250 shares at an average price of $109.46. The price of the stock has decreased by 6.29%. Gilead Sciences has a market cap of $147.82 billion, and its shares were traded at around $102.57. The company has a P/E ratio of 9.40 and P/S ratio of 5.06 with a dividend yield of 0.84%. Over the past five years, Gilead Sciences had an annual average earnings growth of 27.20%.

On Nov. 2, Chairman and CEO John C. Martin sold 150,000 shares at an average price of $109.42. The price of the stock has decreased by 6.26%. On Nov. 9, President and COO John F. Milligan sold 100,000 shares at an average price of $107.66. The price of the stock has decreased by 4.73%. On Nov. 2, EVP, Corp. and Med. Affairs Gregg H. Alton sold 12,000 shares at an average price of $109.38. The price of the stock has decreased by 6.23%.